Trying to lose weight? Be careful not to lose muscle
Is your skin problem actually an autoimmune condition?
People with diabetes face higher risk of hearing loss
Antibiotic-free fixes for recurrent UTIs
Musculoskeletal syndrome of menopause: When menopause makes you ache all over
When can older women stop getting mammograms?
To lose weight, especially harmful belly fat, combine diet and exercise
Can men hold off on treating recurring prostate cancer?
The 7 types of rest and why we need them all
What are the early warning signs of cervical cancer?
Guru P. Sonpavde, MD
Contributor
Guru P. Sonpavde, MD is the director of the bladder cancer program at Dana-Farber Cancer Institute and is on the faculty of Harvard Medical School. He completed his medical oncology fellowship at Indiana University. His primary focus is on clinical trials to develop new drugs and combinations to treat urologic cancers, particularly bladder cancer. He also has led translational projects and developed prognostic classifications and endpoints focused on bladder cancer. He is a member of the Genitourinary Committee of Southwest Oncology Group and the Bladder Cancer Task Force of the National Cancer Institute Genitourinary Steering Committee.
Posts by Guru P. Sonpavde, MD
Guru P. Sonpavde, MD
Cancer treatment: Is a clinical trial right for you?
Guru P. Sonpavde, MD
Immunotherapy: What you need to know
Trying to lose weight? Be careful not to lose muscle
Is your skin problem actually an autoimmune condition?
People with diabetes face higher risk of hearing loss
Antibiotic-free fixes for recurrent UTIs
Musculoskeletal syndrome of menopause: When menopause makes you ache all over
When can older women stop getting mammograms?
To lose weight, especially harmful belly fat, combine diet and exercise
Can men hold off on treating recurring prostate cancer?
The 7 types of rest and why we need them all
What are the early warning signs of cervical cancer?
